| __timestamp | Cytokinetics, Incorporated | Ultragenyx Pharmaceutical Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 17268000 | 10811000 |
| Thursday, January 1, 2015 | 19667000 | 33001000 |
| Friday, January 1, 2016 | 27823000 | 64936000 |
| Sunday, January 1, 2017 | 36468000 | 99909000 |
| Monday, January 1, 2018 | 31282000 | 127724000 |
| Tuesday, January 1, 2019 | 39610000 | 161524000 |
| Wednesday, January 1, 2020 | 52820000 | 182933000 |
| Friday, January 1, 2021 | 96803000 | 219982000 |
| Saturday, January 1, 2022 | 177977000 | 278139000 |
| Sunday, January 1, 2023 | 173612000 | 309799000 |
Infusing magic into the data realm
In the competitive landscape of biotechnology, understanding the financial strategies of leading companies is crucial. This analysis delves into the Selling, General, and Administrative (SG&A) expenses of Cytokinetics, Incorporated and Ultragenyx Pharmaceutical Inc. over the past decade. From 2014 to 2023, Ultragenyx consistently outpaced Cytokinetics in SG&A spending, with a notable peak in 2023 where their expenses reached approximately 310% of Cytokinetics' 2014 figures. This trend highlights Ultragenyx's aggressive investment in administrative and sales functions, potentially reflecting a strategy focused on rapid growth and market penetration. Meanwhile, Cytokinetics exhibited a steady increase, with a significant jump in 2022, marking a 930% rise from their 2014 expenses. This suggests a strategic pivot towards scaling operations. As these companies continue to evolve, their SG&A trends offer valuable insights into their operational priorities and market strategies.
Comparing SG&A Expenses: Novartis AG vs Cytokinetics, Incorporated Trends and Insights
Breaking Down SG&A Expenses: Viatris Inc. vs Cytokinetics, Incorporated
Summit Therapeutics Inc. vs Cytokinetics, Incorporated: SG&A Expense Trends
Breaking Down SG&A Expenses: BioMarin Pharmaceutical Inc. vs Ultragenyx Pharmaceutical Inc.
Breaking Down SG&A Expenses: Sarepta Therapeutics, Inc. vs Ultragenyx Pharmaceutical Inc.
Operational Costs Compared: SG&A Analysis of Walgreens Boots Alliance, Inc. and Cytokinetics, Incorporated
Exelixis, Inc. or Ultragenyx Pharmaceutical Inc.: Who Manages SG&A Costs Better?
Who Optimizes SG&A Costs Better? Cytokinetics, Incorporated or TG Therapeutics, Inc.
Comparing SG&A Expenses: Cytokinetics, Incorporated vs Rhythm Pharmaceuticals, Inc. Trends and Insights
Cytokinetics, Incorporated vs Bausch Health Companies Inc.: SG&A Expense Trends
Comparing SG&A Expenses: Cytokinetics, Incorporated vs Wave Life Sciences Ltd. Trends and Insights
Breaking Down SG&A Expenses: Ultragenyx Pharmaceutical Inc. vs Arrowhead Pharmaceuticals, Inc.